211 related articles for article (PubMed ID: 15356403)
1. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).
Christgau S; Tankó LB; Cloos PA; Mouritzen U; Christiansen C; Delaissé JM; Høegh-Andersen P
Menopause; 2004; 11(5):508-18. PubMed ID: 15356403
[TBL] [Abstract][Full Text] [Related]
2. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application.
Høegh-Andersen P; Tankó LB; Andersen TL; Lundberg CV; Mo JA; Heegaard AM; Delaissé JM; Christgau S
Arthritis Res Ther; 2004; 6(2):R169-80. PubMed ID: 15059281
[TBL] [Abstract][Full Text] [Related]
3. [Study on change of metabolism of articular cartilage in ovariectomized rats in the intervention of different drugs].
Gao F; Du N
Zhongguo Gu Shang; 2008 Mar; 21(3):196-9. PubMed ID: 19105437
[TBL] [Abstract][Full Text] [Related]
4. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation.
Oestergaard S; Sondergaard BC; Hoegh-Andersen P; Henriksen K; Qvist P; Christiansen C; Tankó LB; Karsdal MA
Arthritis Rheum; 2006 Aug; 54(8):2441-51. PubMed ID: 16871544
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene retards cartilage degradation and improves subchondral bone micro-architecture in ovariectomized rats with patella baja-induced - patellofemoral joint osteoarthritis.
Bei MJ; Tian FM; Xiao YP; Cao XH; Liu N; Zheng ZY; Dai MW; Wang WY; Song HP; Zhang L
Osteoarthritis Cartilage; 2020 Mar; 28(3):344-355. PubMed ID: 31326553
[TBL] [Abstract][Full Text] [Related]
6. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J
Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Modulates Cartilage and Subchondral Bone Remodeling in an Ovariectomized Rat Model of Postmenopausal Osteoarthritis.
Xu X; Li X; Liang Y; Ou Y; Huang J; Xiong J; Duan L; Wang D
Med Sci Monit; 2019 Apr; 25():3146-3153. PubMed ID: 31031401
[TBL] [Abstract][Full Text] [Related]
8. The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.
Sondergaard BC; Oestergaard S; Christiansen C; Tankó LB; Karsdal MA
Arthritis Rheum; 2007 Aug; 56(8):2674-8. PubMed ID: 17665432
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D prevents articular cartilage erosion by regulating collagen II turnover through TGF-β1 in ovariectomized rats.
Li S; Niu G; Wu Y; Du G; Huang C; Yin X; Liu Z; Song C; Leng H
Osteoarthritis Cartilage; 2016 Feb; 24(2):345-53. PubMed ID: 26343586
[TBL] [Abstract][Full Text] [Related]
10. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
11. What can be learned from the levormeloxifene experience?
Ravn P; Nielsen TF; Christiansen C
Acta Obstet Gynecol Scand; 2006; 85(2):135-42. PubMed ID: 16532904
[TBL] [Abstract][Full Text] [Related]
12. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance.
Huber C; Collishaw S; Mosley JR; Reeve J; Noble BS
Calcif Tissue Int; 2007 Aug; 81(2):139-44. PubMed ID: 17638036
[TBL] [Abstract][Full Text] [Related]
13. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
[TBL] [Abstract][Full Text] [Related]
14. Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.
Skrumsager BK; Kiehr B; Pedersen PC; Gerrits M; Watson N; Bjarnason K
Br J Clin Pharmacol; 2002 Mar; 53(3):284-95. PubMed ID: 11874392
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
Alexandersen P; Riis BJ; Stakkestad JA; Delmas PD; Christiansen C
J Clin Endocrinol Metab; 2001 Feb; 86(2):755-60. PubMed ID: 11158042
[TBL] [Abstract][Full Text] [Related]
16. Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model.
Park SB; Kim CH; Hong M; Yang HJ; Chung CK
Spine J; 2016 Jan; 16(1):72-81. PubMed ID: 26343247
[TBL] [Abstract][Full Text] [Related]
17. Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats.
Zhu S; Chen K; Lan Y; Zhang N; Jiang R; Hu J
Bone; 2013 Apr; 53(2):340-9. PubMed ID: 23291609
[TBL] [Abstract][Full Text] [Related]
18. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index.
Mouritzen U; Christgau S; Lehmann HJ; Tankó LB; Christiansen C
Ann Rheum Dis; 2003 Apr; 62(4):332-6. PubMed ID: 12634232
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study.
Chavassieux P; Garnero P; Duboeuf F; Vergnaud P; Brunner-Ferber F; Delmas PD; Meunier PJ
J Bone Miner Res; 2001 Jan; 16(1):89-96. PubMed ID: 11149494
[TBL] [Abstract][Full Text] [Related]
20. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
Maeda T; Ke HZ; Simmons H; Thompson D
Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
